Lidocaine 5% Medicated Plasters
Post Herpetic Neuralgia (as per LSCMMG Guidelines)
Lidocaine 5% medicated plasters are recommended as an option for the treatment of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia) in adults.
Initiation should only be after first line topical and systemic therapies have either failed or led to intolerable side effects, as per the LSCMMG Neuropathic Pain Guidance. An assessment of the tolerance and efficacy should be made after 2 – 4 weeks of treatment initiation, before continuation.
After three months of treatment there should be an assessment as to whether the number of patches can be reduced or the patch free interval can be extended.
This colour classification is in agreement with the recommendations contained within the NHS England and NHS Clinical Commissioners guidance document ‘Items which should not routinely be prescribed in primary care: Guidance for CCGs‘ published in November 2017
Reason for decision:
Suitable for initiation in primary care